Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in... by Grau, Santiago, Azanza, Jose Ramon, Ruiz, Isabel, Vallejo, Carlos, Mensa, Josep, Maertens, Johan, Heinz, Werner J, Barrueta, Jon Andoni, Peral, Carmen, Mesa, Francisco Jesús, Barrado, Miguel, Charbonneau, Claudie, Rubio-Rodríguez, Darío, Rubio-Terrés, Carlos

Get full text

Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant by Solano, Carlos, Slavin, Monica, Shaul, Alissa J., Marks, David I., Cordonnier, Catherine, Cornely, Oliver A., Pagliuca, Antonio, Cragin, Lael, Jarque, Isidro, Garcia‐Vidal, Carolina, Sorensen, Sonja, Vanness, David J., Charbonneau, Claudie, Barrueta, Jon Andoni, Peral, Carmen, De Salas‐Cansado, Marina, Bow, Eric J.

Get full text

Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: a post hoc cost-effectiveness analysis in usual medical practice in Sp... by De Salas-Cansado, Marina, Olivares, José M, Alvarez, Enrique, Carrasco, Jose L, Barrueta, Andoni, Rejas, Javier

Get full text

Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain by Ostermann, Helmut, Solano, Carlos, Jarque, Isidro, Garcia-Vidal, Carolina, Gao, Xin, Barrueta, Jon Andoni, De Salas-Cansado, Marina, Stephens, Jennifer, Xue, Mei, Weber, Bertram, Charbonneau, Claudie

Get full text